High resolution melt curve analysis as a tool for screening tyrosine kinase domain mutations in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
Main Authors: | Ang, C.H., Phan, C.L., Gan, G.G., Sultan, M.S., Nadarajan, V. |
---|---|
Format: | Article |
Published: |
Ferrata Storti Foundation
2010
|
Subjects: |
Similar Items
-
Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
by: İbrahim C. Haznedaroğlu
Published: (2013-09-01) -
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
by: Valeria Ciaffaglione, et al.
Published: (2022-05-01) -
WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
by: İbrahim C. Haznedaroğlu, et al.
Published: (2020-02-01) -
DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN TUNISIAN CHRONIC MYELOID LEUKEMIA PATIENTS
by: Rim FRIKHA, et al.
Published: (2023-10-01) -
Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?
by: Avital F. Barak, et al.
Published: (2011-12-01)